Brielle Benyon

Imbruvica plus Breyanzi, a CAR-T cell therapy, improved outcomes in patients with relapsed/refractory chronic lymphocytic leukemia, according to recent research.

A breast surgeon discusses what patients and their caregivers should know before breast cancer surgery.

Without a huge difference in efficacy between many of the available treatments for Waldenstrom’s macroglobulinemia, one expert says patients and their clinicians should look to other factors when deciding which regimen is best.

When LGBTQ+ patients speak up about discriminatory experiences in cancer care, it can help take back the power and pave the way for better care in the future.

Patients should understand the different prognostic scoring systems used in myelofibrosis, and how the results can impact treatment decisions.

After missing his flight, voice actor Rob Paulsen recorded a vlog in the airport where he discusses the “platinum lining” behind his cancer diagnosis when it comes to everyday hassles like travel.

The Food and Drug Administration will review parsaclisib for the treatment of patients with follicular lymphoma, marginal zone lymphoma and mantle cell lymphoma.

The Food and Drug Administration approved Scemblix for patients with Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase whose disease progressed on prior TKI treatment.

Study results showed that CPI-613 did not improve survival in patients with metastatic adenocarcinoma of the pancreas.

Kymriah was granted a priority review for the treatment of pretreated patients with relapsed or refractory follicular lymphoma.

Some patients with small kidney tumors may be able to forego treatment and have regular medical checkups instead.

Women with a myeloproliferative neoplasm can have healthy pregnancies, as long as they coordinate their care and know what to look out for.

Dr. Ami P. Vaidya tells patients and their loved ones what to expect when they opt for cancer genetic testing.

Myeloma survivors, their loved ones and clinicians trekked up the Alaska-Kenai Peninsula to raise money and funds for the disease, offering one nurse the inspiration she needed after more than a year of the COVID-19 pandemic.

A doctor helps put patients at ease when it comes to undergoing genetic testing after a cancer diagnosis and explains why it is important to do so.

Elacestrant improved progression-free survival in patients with ER-positive/HER2-negative advanced or metastatic breast cancer.

The ESPN sportscaster Dick Vitale was diagnosed with lymphoma, after receiving a melanoma diagnosis earlier this year.

Knowing the type, phase and eligibility criteria is key in reading cancer research.

The Food and Drug Administration approved adjuvant Tecentriq for patients with PD-L1—positive, stage 2 to 3A non-small cell lung cancer.

Data from a phase 3 trial show that frontline tremelimumab plus Imfinzi improved overall survival in patients with liver cancer.

After being diagnosed with cancer, patients should see their dentist as soon as possible, explained Dr. Susan Calderbank.

A psychologist offers three aspects to think about before making a cancer treatment or prevention decision.

Fans and fellow “Oz” stars had rallied around Granville Adams through a GoFundMe page that raised more than $100,000 for cancer treatments and medical bills prior to his death.

An expert and a patient discuss their experiences with Tecartus, the newly approved CAR-T cell therapy for certain patients with acute lymphoblastic leukemia.

The World Health Organization updated their Model Lists of Essential Medicines to include more cancer treatments, though some popular cancer drugs were excluded from the list.

Patients with myeloma should not be afraid to seek out second opinions or speak up about side effects that they are experiencing.

The FDA approved Tecartus, a CAR-T cell therapy, for the treatment of patients with relapsed/refractory acute lymphoblastic leukemia.

Lifestyle factors like diet and exercise can play a major role in cancer outcomes. In this article, a clinical dietitian offers advice on healthy eating before and after a cancer diagnosis.

Clinical trials are key in driving treatment advancements for patients with cancer – especially those with genetic mutations – and should not be looked at as a last resort.

The new approach of chemotherapy plus Opdivo offers “the best of both treatment approaches,” says one expert.